Recruiting Melanoma Studies in Grand Rapids
Neoadjuvant Darovasertib in Primary Uveal Melanoma
This is a Phase 3, randomized, multi-center, open-label study of neoadjuvant darovasertib in subjects with primary non-metastatic uveal melanoma (OptimUM-10)...
(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma
Neoadjuvant/adjuvant IDE196 (darovasertib) in patients with primary uveal melanoma...
About Melanoma Clinical Trials in Grand Rapids
Melanoma is the most serious type of skin cancer, developing from the pigment-producing cells known as melanocytes. While less common than other skin cancers, melanoma is more likely to spread. Immunotherapy and targeted therapy have revolutionized melanoma treatment.
There are currently 2 melanoma clinical trials recruiting participants in Grand Rapids, MICHIGAN. These studies are seeking a combined 602 participants. Research is being sponsored by IDEAYA Biosciences. Clinical trial participation is free and participants receive study-related medical care at no cost.
Melanoma Clinical Trials in Grand Rapids — FAQ
Are there melanoma clinical trials in Grand Rapids?
Yes, there are 2 melanoma clinical trials currently recruiting in Grand Rapids, MICHIGAN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Grand Rapids?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Grand Rapids research site will contact you about next steps.
Are clinical trials in Grand Rapids free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Grand Rapids studies also compensate for your time and travel.
What melanoma treatments are being tested?
The 2 active trials in Grand Rapids are testing new therapies including novel drugs, biologics, and treatment approaches for melanoma.
Data updated March 2, 2026 from ClinicalTrials.gov